Page 23 - Situation Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

8.2.3 Wellness Hurts 8.3 Instrumentation and Automation 8.3.2 The Shrinking Machine 8.4 Diagnostic Technology Development 8.4.2 POCT/Self Testing as a Disruptive Force 8.4.3 The Genetics Play - One Test for All Known Infections 8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 9 Molecular Dx - Infectious Disease Recent Developments 9.1 Recent Developments - Importance and How to Use This Section 9.1.1 Importance of These Developments 9.1.2 How to Use This Section 9.2 Roche to Acquire GenMark Diagnostics for $1.8B 9.3 Lucira Health Focuses on User Friendly Approach to Home Testing 9....

7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequenci...

7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequenci...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Cancer Panels & Profiles Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigen...

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations. Working against this dynamic market are the f...